TLCR Reading Tools
How to cite item
The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{69408}, author = {Chen, B., Wang, J., Pu, X., Li, J., Wang, Q., Liu, L., Xu, Y., Xu, L., Kong, Y., Li, K., Xu, F., Liang, S., Cardona, A., Wu, L.}, title = {The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort study}, journal = {Translational Lung Cancer Research}, volume = {11}, number = {10}, year = {2022}, url = {https://tlcr.amegroups.org/article/view/69408} }